Shares of Provention Bio Inc (NASDAQ: PRVB) more than tripled on Monday after Sanofi S.A. (EPA: SAN) confirmed plans of buying the biopharmaceutical company that focused on autoimmune diseases. Here’s...
Tag: Biopharma
Ginkgo Has Hired A New Head Of Biopharma To Disrupt The Gene And Cell Therapies Market
Behzad Mahdavi, Senior Vice President Biopharma Manufacturing & Life Sciences Tools at Ginkgo … [+] Bioworks. Ginkgo Bioworks Cell and gene therapies may be the most anticipated invention of...
This Biopharma ‘Fits the Bill’ as a Growth Play
With the economy looking like it is heading towards recession in 2023, reliable growth names with reasonable valuations are in short supply in the current market. One name that fits that bill is a bio...
This biopharma stock more than doubled on Monday: find out more
Shares of Imago Biosciences Inc (NASDAQ: IMGO) opened more than 100% up this morning after Merck & Co Inc (NYSE: MRK) said it will acquire the biopharmaceutical firm in a $1.35 billion deal. Imago...
Twist Bioscience Revenue Growing From $2 To $200 Million As It Eyes The $186 Billion Antibody Market
Emily Leproust, Patrick Finn, Aaron Sato, and Tracey Mullen of Twist Bioscience. Twist Bioscience It’s another beautiful sunny day in San Francisco, and Twist Bioscience (NASDAQNDAQ : TWST) is making ...
This little-known biopharma stock could rally 70%: Goldman Sachs
Gossamer Bio Inc (NASDAQ: GOSS) is in the green on Thursday after a Goldman Sachs analyst said the stock is ready for another huge move to the upside. Gossamer Bio stock could rally to $22 On Thursday...
Helix Biopharma Corp. Announces Closure of Early Warrant Exercise Incentive Program
Toronto, Ontario –News Direct– Helix BioPharma Corp. Helix BioPharma Corp. (Richmond Hill, Ontario) – TheNewswire – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a cli...